KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Long-Term Investments (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Long-Term Investments for 18 consecutive years, with $9.8 billion as the latest value for Q1 2026.

  • For Q1 2026, Long-Term Investments rose 5.49% year-over-year to $9.8 billion; the TTM value through Mar 2026 reached $9.8 billion, up 5.49%, while the annual FY2025 figure was $10.3 billion, 15.29% up from the prior year.
  • Long-Term Investments hit $9.8 billion in Q1 2026 for Regeneron Pharmaceuticals, down from $10.3 billion in the prior quarter.
  • Across five years, Long-Term Investments topped out at $10.3 billion in Q3 2025 and bottomed at $5.4 billion in Q4 2023.
  • Average Long-Term Investments over 5 years is $7.7 billion, with a median of $7.1 billion recorded in 2022.
  • Year-over-year, Long-Term Investments surged 99.9% in 2022 and then decreased 18.13% in 2023.
  • Regeneron Pharmaceuticals' Long-Term Investments stood at $6.6 billion in 2022, then decreased by 18.13% to $5.4 billion in 2023, then skyrocketed by 64.92% to $8.9 billion in 2024, then increased by 15.29% to $10.3 billion in 2025, then decreased by 4.63% to $9.8 billion in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $9.8 billion, $10.3 billion, and $10.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.